Executive Summary
Amazon files a response defending the PTAB’s institution of its IPR against NL Giken, arguing the Board’s claim constructions are correct and discretionary denial is inappropriate.
Related Cases
Nintendo Co., Ltd. et al.vsMalikie Innovations Ltd.
Nintendo and Malikie Innovations settled their IPR dispute, leading the Board to dismiss the petitions and terminate the proceedings.
Samsung Electronics Co., Ltd. et al.vsOura Health Oy et al.
The PTAB granted institution for a high-stakes IPR concerning wearable biosensor technology, specifically smart rings. The Board found sufficient evidence of obviousness (103) and anticipation (102) to proceed with trial on 17 claims.
Imperative Care, Inc.vsInari Medical, Inc. et al.
Imperative Care has filed an IPR petition seeking to invalidate Inari Medical’s 12,239,333 patent covering clot‑removal devices. The petition relies on multiple prior‑art references to argue anticipation and obviousness of the asserted claims. The Board must decide whether to institute the review.
Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University
Merck Sharp & Dohme LLC successfully secured institution for its IPR challenge against The Johns Hopkins University regarding oncology/immunotherapy claims. The Board found sufficient evidence to proceed under 35 U.S.C. § 102 and § 103, despite procedural challenges from the Patent Owner.
Dead Air Silencers et al.vsJarvis Arms LLC
The PTAB granted institution for IPR2026-00013, allowing Dead Air Silencers et al. to challenge Jarvis Arms LLC's patent 12018906 after finding a reasonable likelihood of prevailing.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.